These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 20656362)

  • 21. The cost-effectiveness of direct-to-consumer advertising for prescription drugs.
    Atherly A; Rubin PH
    Med Care Res Rev; 2009 Dec; 66(6):639-57. PubMed ID: 19423875
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antihypertensive drug prescribing in Grampian.
    Ross S; Macleod MJ
    Br J Clin Pharmacol; 2005 Sep; 60(3):300-5. PubMed ID: 16120069
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of new drugs on overall health spending: Frank Lichtenberg responds.
    Lichtenberg FR
    Health Aff (Millwood); 2007; 26(3):887-90. PubMed ID: 17485771
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Is the pharmacological treatment of mild to moderate hypertension cost effective in stroke prevention?
    Malcolm LA; Kawachi I; Jackson R; Bonita R
    N Z Med J; 1988 Apr; 101(843):167-71. PubMed ID: 3128747
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Drug expenditures for hypertension: an empirical test of an economic model in a French population.
    Huttin C; Avorn J
    Cah Sociol Demogr Med; 1997; 37(1):33-52. PubMed ID: 9239318
    [No Abstract]   [Full Text] [Related]  

  • 26. The effects of antihypertensive step-therapy protocols on pharmaceutical and medical utilization and expenditures.
    Mark TL; Gibson TB; McGuigan KA
    Am J Manag Care; 2009 Feb; 15(2):123-31. PubMed ID: 19284809
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The 2000 Canadian recommendations for the management of hypertension: Part one--therapy.
    McAlister FA; Levine M; Zarnke KB; Campbell N; Lewanczuk R; Leenen F; Rabkin S; Wright JM; Stone J; Feldman RD; Lebel M; Honos G; Fodor G; Burgess E; Tobe S; Hamet P; Herman R; Irvine J; Culleton B; Petrella R; Touyz R;
    Can J Cardiol; 2001 May; 17(5):543-59. PubMed ID: 11381277
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A retrospective analysis comparing the costs and cost effectiveness of amlodipine and enalapril in the treatment of hypertension.
    Doyle J; Omvik P; Arikian S; Casciano J; Casciano R; Gonzalez MA; Arocho R
    Manag Care Interface; 2001 Mar; 14(3):82-7. PubMed ID: 11301961
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treating mild to moderate hypertension: cost-effectiveness and policy implications.
    Kawachi I; Malcolm LA
    J Cardiovasc Pharmacol; 1990; 16 Suppl 7():S126-8. PubMed ID: 1708013
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prescription drug accessibility and affordability in the United States and abroad.
    Morgan S; Kennedy J
    Issue Brief (Commonw Fund); 2010 Jun; 89():1-12. PubMed ID: 20614652
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cost-benefit aspects of treatment of hypertension in the elderly.
    Lindholm LH; Johannesson M
    Blood Press Suppl; 1995; 3():11-4. PubMed ID: 8535536
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Medical and cost-economy aspects of modern antihypertensive therapy--with special reference to 2 years of clinical experience with losartan.
    Hansson L
    Blood Press Suppl; 1997; 1():52-5. PubMed ID: 9285110
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evidence-based benefit assessment of pharmaceuticals as a basis for rational and economical pharmaceutical therapy.
    Müller T
    Eur J Health Econ; 2008 Nov; 9 Suppl 1():1-3. PubMed ID: 18987904
    [No Abstract]   [Full Text] [Related]  

  • 34. Do newer agents confer added cost-benefit in the management of hypertension?
    Seedat YK
    S Afr Med J; 1988 Dec; 74(11):543-4. PubMed ID: 3143158
    [No Abstract]   [Full Text] [Related]  

  • 35. The cost-effectiveness of antihypertensive drugs.
    Kaplan NM
    JAMA; 1990 Jun; 263(21):2888-9. PubMed ID: 2110984
    [No Abstract]   [Full Text] [Related]  

  • 36. Ending the French love affair with drugs.
    Arie S
    BMJ; 2012 Oct; 345():e6996. PubMed ID: 23077372
    [No Abstract]   [Full Text] [Related]  

  • 37. Hypertension treatment at the crossroads: a role for economics?
    Arno PS; Viola D
    Am J Hypertens; 2013 Nov; 26(11):1257-9. PubMed ID: 24048145
    [No Abstract]   [Full Text] [Related]  

  • 38. Hypertension and its effects on the economy of the health system for patients and society: suggestions for developing countries.
    Arredondo A; Avilés R
    Am J Hypertens; 2014 Apr; 27(4):635-6. PubMed ID: 24610899
    [No Abstract]   [Full Text] [Related]  

  • 39. Response to "Hypertension and its effects on the economy of the health system, for patients and society: suggestions for developing countries".
    Arno PS; Viola D
    Am J Hypertens; 2014 Apr; 27(4):637. PubMed ID: 24610900
    [No Abstract]   [Full Text] [Related]  

  • 40. New horizons in pharmaceutical technology.
    Kirking DM
    Ann Am Acad Pol Soc Sci; 1983 Jul; (468):182-95. PubMed ID: 10310115
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.